Vanderhoeven J, McAdams RM, Beyer RP, Bammler TK, Farin FM, Rajagopal L, Kapur RP, Bansal A, Spencer M, Deng M, Gravett MG, Rubens CE, Adams Waldorf KM (2014). Group B streptococcal infection of the choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: A pathway to premature membrane rupture. PLoS Pathogens, 10(3): e1003920.

Weinert C, Cudney S, Comstock B, Bansal A. A computer based intervention for illness self-management among rural women with chronic health conditions: A randomized parallel-group study. Canadian Journal of Nursing Research, in press.

Khandelwal N, Hough CL, Bansal A, Veenstra DL, Treggiari MM. Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia. Critical Care Medicine, in press.

Solorio R, Bansal A, Comstock B, Ulatowski K (2015). Impact of a chronic care coordinator intervention on diabetes quality of care in a community health center. Health Services Research, 50(3): 730-749. Shiovitz S, Bansal A, Burnett-Hartman AN, Karnopp A, Adams SV, Korenbot C, Warren-Mears V, Ramsey S (2015).

Cancer-directed therapy and hospice care for metastatic cancer in American Indians and Alaska Natives. Cancer Epidemiology, Biomarkers & Prevention, 24(7): 1138-1143.

Shankaran V, Mummy D, Kopel L, Bansal A, Mirich DK, Yu E, Morlock R, Ramsey SD (2014). Survival and lifetime costs associated with first-line bevacizumab use in older patients with metastatic colorectal cancer. The Oncologist, 19(8): 892-899

Bansal A, Radich JP (2016). Is cure for CML possible in the TKI era? Current Opinion in Hematology, 23(2): 115-120.

Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, Newcomb P. Financial insolvency as a risk factor for early mortality among patients with cancer (2016). Journal of Clinical Oncology, 34(9): 980-986.

Othus M, Bansal A, Koepl L, Wagner S, Ramsey S. Accounting for cured patients in cost-effectiveness analysis. Value in Health, in press.

Bansal A, Sullivan SD, Lyman G, Hershman D, Barlow WE, McCune J, Ramsey SD (2017). A Stakeholder-Informed Randomized, Controlled Comparative Effectiveness Study of an Order Prescribing Intervention to Improve Colony Stimulating Factor use for Cancer Patients Receiving Myelosuppressive Chemotherapy, (SWOG S1415CD): The TrACER Study. Journal of Comparative Effectiveness Research, doi: 10.2217/cer-2017-0005. [Epub ahead of print] .

Bansal A, Radich JP (2016). Is cure for CML possible in the TKI era? Current Opinion in Hematology, 23(2): 115-120.

Othus M, Bansal A, Koepl L, Wagner S, Ramsey S (2017). Accounting for cured patients in cost-effectiveness analysis. Value in Health. 20(4): 705‐709.

An up-to-date list of publications can be found here.

Basu A. Person-Centered Treatment (PeT) effects using instrumental variables: An application to evaluating prostate cancer treatments.. 2012 National Bureau of Economic Research Working Paper No w18056. Journal of Applied Econometrics In Press

Basu A, Meltzer D. Private manufacturers’ thresholds to invest in comparative effectiveness trials. PharmacoEconomics 2012; 30(10): 859-868.

Borah B, Basu A. Highlighting differences between conditional and unconditional quantile regression approaches through an application to assess medication adherence. Health Economics In press

Basu A. Chan KCG. Can we make smart choices between OLS versus Contaminated IV estimators? Health Economics 2014; 23(4):462-72.

Basu A. Personalized Medicine in the Context of Comparative Effectiveness Research. Forum for Health Economics and Policy 2013; 16(2): 107-120.

Basu A, Jena AB, Goldman DP, Philipson TJ, Dubois R. Heterogeneity in action: Role of passive personalization in comparative effectiveness research. Health Economics (with Discussions) 2013; 23(3): 359 – 373.

Basu A. Financing Cures in the United States. Expert Review of Pharmacoeconomics and Outcomes Research 2015; 15(1): 1-4.

Basu A. Welfare implications of learning through solicitation versus diversification in health care. NBER Working paper # 20367. Journal of Health Economics 2015; 42: 165-173.

Basu A, Gore J. Are elderly patients with clinically localized prostate cancer overtreated? Exploring heterogeneity in survival effects. Medical Care 2015; 53(1):79-96.

Basu A, Subedi P, Kamal-Bahl S. Financing a cure for diabetes in a multi-payer environment. Value in Health 2016 In press.

Basu A, Carlson JJ, Veenstra DL. A framework for prioritizing research investments in precision medicine. Medical Decision Making 2016 In Press.

Basu A, Axelsen K, Grabaowski DC, Meltzer DO, Polsky D, Ridley DB, Wiederkehr D, Philipson TJ. Real World Data: Policy issues regarding their access and use. Medical Care 2016 In press.

Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG. Recommendations for Conduct, Methodological Practices, and Reporting of Cost-Effectiveness Analyses in Health and Medicine: The Second Panel on Cost-Effectiveness in Health and Medicine. Journal of the American Medical Association 2016; 316(10): 1093- 1103.

Basu A, Sullivan SD. Towards a hedonic value framework in health care. Value in Health 2017; 20: 261-265.

Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD. Impact of a Value-Based Formulary on Medication Utilization, Health Services Utilization, and Expenditures. Medical Care 2017; 55(2): 191-198.

Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, HorikePyne M, Hisama FM, Pritchard CC, Grady WM, Burke W, Jarvik GP, Veenstra DL. Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis. J Clin Oncol. 2015 Jun 20;33(18):2084-91. doi: 10.1200/JCO.2014.59.3665. Epub 2015 May 4.

Bennette CS, Gallego CJ, Burke W, Jarvik GP, Veenstra DL. The cost effectiveness of returning incidental findings from next-generation genomic sequencing. Genet Med. 2015 Jul 2;17(7):587-95. doi: 10.1038/ gim.2014.156. Epub 2014 Nov 13.

Bennette CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL. Predicting low accrual in the National Cancer Institute’s Cooperative Group Clinical Trials . Journal of the National Cancer Institute. 2015 Dec 29;108(2).

Bennette CS, Veenstra DL, Basu A, Baker L, Ramsey SD, Carlson JJ. Development and evaluation of an approach to using Value of Information Analyses for real-time prioritization decisions within SWOG-a large clinical trials cooperative group. Medical Decision Making. July 2016. 36 (5), 641-651.

Bennette CS, Richards C, Sullivan SD, Ramsey SD. Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure. Health Affairs. May 2016 vol. 35 no. 5 805-812

Boudreau DM, Arterburn D, Bogart A, Haneuse S, Theis MK, Westbrook E, Simon G. Influence of body mass index on the choice of therapy for depression and follow-up care. Obesity. 2013;21:E303-13.

Boudreau DM, Yu O, Spangler L, Do TP, Fujii M, Ott SM, Critchlow CW, Scholes D. Accuracy of ICD-9 codes to identify Nonunion and Malunion & Developing Algorithms to Improve Case-Finding of Nonunion and Malunion. Bone. 2013;52:596-601. Epub 2012. Nov 19.

Calip GS, Boudreau DM, Loggers ET. Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment. Breast Cancer Res Treat. 2013;138:225-33.

Raebel MA, Newcomer SR, Bayliss EA, Boudreau DM, DeBar L, Elliott TE, Ahmed A, Pawloski PA, Fisher D, Toh S, Donahoo WT. Chronic Opioid Use Emerging after Bariatric Surgery. Pharmacoepidemiol Drug Saf. 2014. In press.

Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJA, Fujii M, Buist DSM. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early-stage breast cancer. Breast Cancer Res Treat. 2014 Feb 21. [Epub ahead of print]

Roth JA, Boudreau D,* Fujii MM, Farin FM, Rettie AE, Thummel KE, Veenstra DL. Genetic risk factors for major bleeding in long-term Warfarin patients in a community setting. Clinical Pharmacology & Therapeutics. 2014. In press.

Boudreau DM, Guzauskas GF, Chen E, Lalla D, Tayama D, Fagan SC, Veenstra DL. Cost-Effectiveness of Recombinant Tissue Plasminogen Activator within 3 Hours of Acute Ischemic Stroke using Current Evidence. Stroke. 2014;45:3032-39.

Boudreau DM, Yu O, Chubak J, Wirtz HS, Bowles EJ, Fujii M, Buist DS. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early-stage breast cancer. Breast Cancer Res Treat. 2014;144:405-16.

Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau DM*. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting. Pharmacoepidemiol Drug Saf. 2015 Apr 8. [Epub ahead of print]

Calip GS, Yu O, Elmore JG, Boudreau DM. Comparative Safety of Diabetes Medications and Risk of Incident Invasive Breast Cancer: A Population-Based Cohort Study. Cancer Causes & Control. 2016 Apr 6. [Epub ahead of print]

Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting. Pharmacoepidemiol Drug Saf. 2015;24:619-27.

Arterburn D, Sofer T, Boudreau DM, Bogart A, Westbrook EO, Theis MK, Simon GE, Haneuse S. Long-term weight change after initiating second-generation antidepressants. J Clin Med. 2016 Apr 13;5(4).

Boudreau DM, Yu O, Balasubramanian A, Wirtz H, Grauer A, Crittenden DB, Scholes D. A Survey of Adult Awareness and Reasons for Lack of Post-Fracture Osteoporotic Care. J Am Geriatr Soc. 2017 Apr 19. [Epub ahead of print].

Wirtz HS, Calip GS, Buist DSM, Gralow JR, Barlow WE, Gray S, Boudreau DM*. Evidence for detection bias in breast cancer pharmacoepidemiology studies. Am J Epidemiol. 2017;185:661-672.

Calip GS, Elmore JG, Boudreau DM. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. Breast Cancer Res Treat. 2017;161:161-172

Johnson FR, Lancsar E, Marshall D, Kilambi V, Mühlbacher A, Regier D, Bresnahan B, Kanninen B, Bridges J. Constructing experimental designs for discrete-choice experiments: Report of the ISPOR conjoint analysis experimental design good research practices task force. Value in Health, 2013; 16:3-13.

Bresnahan, BW, Rundell, SD, Dagadakis, MC, Sullivan, SD, Jarvik, JG, Nguyen, H, Friedly, JL. Assessing epidural steroid injections for lumbar spinal stenosis: systematically reviewing the comparative literature and estimating reimbursement amounts, Physical Medicine & Rehabilitation, In press

O’Conner, SS, Whitehill, JM, King, KM, Kernic, MA, Boyle, L, Bresnahan, B, Mack, CD, Ebel, BE. Compulsive cell phone use and history of motor vehicle crash, Journal of Adolescent Health, In press

Bresnahan, BW, Rundell, SD, Dagadakis, MC, Sullivan, SD, Jarvik, JG, Nguyen, H, Friedly, JL. Assessing epidural steroid injections for lumbar spinal stenosis: systematically reviewing the comparative literature and estimating reimbursement amounts, PM&R, August 2013; 5:705-714.

Bresnahan, BW and Garrison, LP Jr.. Diagnostic imaging, Economic issues in: Anthony J Culyer (ed.), Encyclopedia of Health Economics, Vol. 1. San Diego: Elsevier; 2014. pp.189- 199.

Cronin P, Kelly A, Sanelli P, Lee J, Heilbrun M, Bresnahan BW, Rawson J, Paladin A, How to Report a Research Study and Appraise the Literature, Acad Rad, August 2014, (epub ahead of print).

Andre JB, Bresnahan BW, Mossa-Basha M, Hoff MN, Smith CP, Anzai Y, Cohen WA.Toward Quantifying the Prevalence, Severity, and Cost Associated With Patient Motion During Clinical MR Examinations. J Am Coll Radiol. 2015 Jul;12(7):689-95. doi: 10.1016/j.jacr.2015.03.007. Epub 2015 May 9. PMID: 25963225

Jarvik JG, Gold LS, Comstock BA, Heagerty PJ, Rundell SD, Turner JA, Avins AL, Bauer Z, Bresnahan BW, Friedly JL, James K, Kessler L, Nedeljkovic SS, Nerenz DR, Shi X, Sullivan SD, Chan L, Schwalb JM, Deyo RAAssociation of early imaging for back pain with clinical outcomes in older adults. JAMA. 2015 Mar 17;313 (11):1143-53. doi: 0.1001/ jama.2015.1871. Erratum in: JAMA. 2015 May 5;313(17):1758. PMID: 25781443

Duong PA, Bresnahan B, Pastel DA, Sadigh G, Ballard D, Sullivan JC, Buch K, Duszak R Jr., Value of Imaging Part I: Perspectives for the Academic Radiologist, Acad Radiol. 2016 Jan;23 (1):18-22. doi: 10.1016/j.acra.2015.10.006. Epub 2015 Nov 10, PMID: 26683508.

Roudsari B, McWilliams J, Bresnahan BW, Padia S, Introduction to cost analysis in interventional radiology: challenges and opportunities, J Vasc Interv Radiol. 2016 Feb 25. pii: S1051-0443(15) 02009-6. doi: 10.1016/j.jvir.2015.12.754. [Epub ahead of print] Review. PMID: 26922978.

Hippe, DS, Lehnert, BE, Slade, I, Dellit, TH, Hough, CL, Schreuder, AB, Cohen, WA, Miklusis, J, Pergamit, R, Bresnahan, BW, Reducing utilization of portable chest radiographs in the intensive care unit: a quality improvement initiative, JACR, June 2017, in print.

Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD. Estimating the Cost Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Clin Ther. 2013 Apr;35(4):414-24.

Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, Deverka P, Ramsey SD, Veenstra DL. Value of Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics. Medical Decision Making. Med Decis Making. 2013 May;33 (4):463 -71

Carlson JJ, Ramsey SD. Proof or principle? On economic modeling to guide genomic testing in metastatic colorectal cancer. J Natl Cancer Inst. 2012 Dec 5;104 (23):1779-80.

Roth, JA., Billings, P., Ramsey, SD., Dumanois, R., Carlson, JJ. Cost-Effectiveness of a 14-Gene Risk Score Assay to Target Adjuvant Chemotherapy in Early Stage NonSquamous Non-Small Cell Lung Cancer. The Oncologist. 2014, In Press.

Carlson, JJ., Gries, K., Yeung, K., Sullivan, SD., Garrison, LP. Current Status and Trends in Performance-Based RiskSharing Arrangements between Healthcare Payers and Medical Product Manufacturers. Applied Health Economics and Health Policy. 2014, In Press.

Towse, A, Ossa, D, Veenstra, DL, Carlson, JJ, Garrison, LP. Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned. J. Pers. Med. October, 2013

Carlson JJ, Ogale S, Dejonckheere F, Sullivan SD. Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis. Value Health. Mar 2015;18(2):173-179.

Campbell JD, McQueen RB, Libby AM, Spackman DE, Carlson JJ, Briggs A. Cost-effectiveness Uncertainty Analysis Methods: A Comparison of One-way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information. Med Decis Making. Oct 27 2014.

Canestaro, W, Carlson JJ, Garrison, LP, Veenstra DL. Cost Effectiveness, Economic Incentives, and Reimbursement Issues. Chapter 17. In Pharmacogenomics: Applications to Patient Care, 3rd Ed.. American College of Clinical Pharmacy.

Yu JS, Hansen RN, Valderrama A, Carlson JJ. Indirect costs and workplace productivity loss associated with non-Hodgkin lymphoma. Leuk Lymphoma. 2016:1-8.

Bennette CS, Veenstra DL, Basu A, Baker LH, Ramsey SD, Carlson JJ. Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group. Med Decis Making. 2016.

Bennette CS, Ramsey SD, McDermott CL, Carlson JJ, Basu A, Veenstra DL. Predicting Low Accrual in the National Cancer Institute’s Cooperative Group Clinical Trials. J Natl Cancer Inst. 2016;108(2).

Basu A, Carlson JJ, Veenstra DL. A Framework for Prioritizing Research Investments in Precision Medicine. Med Decis Making. Oct 26 2015; ePub.

Carlson JJ, Chen S, Garrison LP, Jr. Performance-Based RiskSharing Arrangements: An Updated International Review. Pharmacoeconomics. 2017.

Adamson BJS, Carlson JJ, Kublin JG, Garrison LP. The Potential Cost-Effectiveness of Pre-Exposure Prophylaxis Combined with HIV Vaccines in the United States. Vaccines (Basel). 2017;5(2).

Yu JS, Hansen RN, Valderrama A, Carlson JJ. Indirect costs and workplace productivity loss associated with non-Hodgkin lymphoma. Leuk Lymphoma. 2016;57(11):2636-2643.

Devine EB, Van Eaton E, Yanez ND, Capurro D, Devlin A, Flum DR, Tarczy-Hornoch P, for the SCOAP CERTAIN Corporate Authorship. Preparing Electronic Clinical Data for Quality Improvement and Comparative Effectiveness Research: The CERTAIN Automation and Validation Project. Generating Evidence & Methods to improve patient outcomes (eGEMS), In press August 2013)

Devine EB, Edwards T, Patrick DL, Alfonso-Cristancho R, Yanez ND, Devlin A, Symons R, Flum DR, for the SCOAP CERTAIN Corporate Authorship. A Model for Incorporating Patient and Stakeholder Voices in a Learning Healthcare Network: Washington State’s Comparative Effectiveness Research Translation Network (CERTAIN). J Clin Epi 2013;66:S122e-S129

Overby CL, Devine EB, Tarczy-Hornoch P, Kalet. Deriving rules and assertions from pharmacogenomic knowledge resources In support of patient drug exposure predictions. J Am Med Inform Assoc. 2012;19:840-850

Agapova M, Devine EB, Nguyen H, Inoue L, Wolf F. Comparing results of frequentist and Bayesian approaches to explore the comparative effectiveness of subgroups in a Cochrane Systematic Review (in press at J Comp Eff Res, May 2014)

Forrester S, Hepp Z, Roth J. Wirtz HS, Devine EB. Cost-effectiveness of a computerized provider order entry system in improving medication safety in ambulatory care. Value Health, 2014 Jun;17(4):340-9. doi: 10.1016/ j.jval.2014.01.009. Epub 2014 May 5 *Publication recognized with press release from ISPOR Value in Health, May 2014

Lau B, Overby CL, Wirtz HS, Devine EB. Use of a clinical decision support tool in the ambulatory setting to improve adherence to national monitoring guidelines for medication laboratory tests. Appl Clin Inf 2013 Oct 16;4(4):476-98. doi: 10.4338/ACI-2013-06-RA-0041

Vodicka E, Kim K, Devine EB, Gnanasakthy A, Patrick DL. The use of patient-reported outcome instruments in clinical trials. Contemp Clinical Trials, 2015;43:1-9. doi: 10.1016/j.cct.2015.04.004

Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015 Jan 13. doi: 10.7326/M14-2559

Hersh W, Totten A, Eden K, Devine B, Gorman P, Kassakian S, Woods S, Daeges M, Pappas M, McDonagh M. Health Information Exchange. Evidence Report/Technology Assessment No. ##. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. HHSA 290201200014I.) AHRQ Publication No. ##. Rockville, MD: Agency for Healthcare Research and Quality; April 2015. www.effectivehealthcare.ahrq.gov

Devine EB, Alfonso-Cristancho R, Yanez ND, Edwards TC, Patrick DL, Armstrong CAL, Devlin A, Symons RG, Meissner MH, Thomason EL, Lavallee DC, Kessler LG, Flum DR, and CERTAIN Collaborative. Patient-Reported Outcomes after Medical versus Revascularization Interventions for Intermittent Leg Claudication. (in press at JAMA Surg, August 2016)

Canestaro WJ, Forrester SH, Devine EB. Drug therapy for treatment of idiopathic pulmonary fibrosis: Systematic review and network meta-analysis. Chest 2016;149(3):756-66

Agapova M, Garrison LP, Bresnahan B, Johnson R, Higashi M, Kessler L, Devine EB. Development of a decision aid for quantitative evaluation of benefits and risks in diagnostic imaging. (in press at J Eval Clin Pract, August 2016)

Mathias PC, Hendrix N, Wang WJ, Keyloun KR, Khelifi M, TarczyHornoch P, Devine B. Characterizing pharmacogenomic-guided medication use with a clinical data repository. Clin Pharmacol Ther. 2017 Jan 10. doi: 10.1002/cpt.611. [Epub ahead of print]

Chin L, Devine B, (co-primary authors) Baradaran S, Keyloun K, Canestaro WJ, Pham J. Characterizing the strength of evidence in FDA Labels for pharmacogenomic biomarker-guided medication use. AMIA Jt Summits Transl Sci Proc. 2017 Jul

Agapova M, Bresnahan B, Linnau KF, Garrison LP, Higashi M, Kessler L, Devine EB. Using the Analytic Hierarchy Process for Prioritizing Imaging Tests in Diagnosis of Suspected Appendicitis Academic Radiology. Acad Radiol. 2017 May;24(5):530-537. doi: 10.1016/ j.acra.2017.01.001. Epub 2017 Mar 28.

Garrison LP, Jr. (co-chair); Towse A (co-chair) et al. Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for PerformanceBased Risk-Sharing Arrangements Task Force, Value in Health, August, 2013

Garrison LP, Jr., Lalla D, et al. Assessing the Potential Cost-Effectiveness of Retesting IHC0, IHC1, or FISHNegative Early Stage Breast Cancer Patients for HER2 Status, Cancer, June (epub), 2013

Garrison LP Jr. Universal health coverage–big thinking versus big data. Value Health. 2013 Jan-Feb;16(1 Suppl):S1

Garrison LP, Jr. (co-chair); Towse A (co-chair) et al. Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based RiskSharing Arrangements Task Force, Value in Health, August, 2013

Garrison LP and Towse A. Economics of Personalized Medicine: Pricing and Reimbursement Policies as a Potential Barrier to Development and Adoption. Chapter in: Culyer T, editor. Encyclopedia of Health Economics. Oxford: Elsevier; 2014.

Garrison LP. Pharmacoeconomics and Drug Pricing. Chapter 8 in Ho and Gibaldi’s Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes into Drugs, Second Edition, Rodney J. Y. Ho and Milo Gibaldi, John Wiley and Sons, 2013

Garrison LP, Carlson JJ, Bajaj PS, Towse A, Neumann PJ,, Sullivan SD, Westrick KD, Dubois RW. Private Sector Risk-Sharing Agreements in the U.S.: Trends, Barriers, and Prospects, Forthcoming AJMC.

Garrison LP, Babigumira JB, Masaquel A, Wang B, Lalla D, Brammer M. The lifetime economic burden of inaccurate HER2 testing: estimating the costs of false positive and false negative HER2 test results in US patients with early-stage breast cancer. Value in Health; 2015 Jun;18(4):541-6

Agapova M, Devine EB, Bresnahan BW, Higashi MK, Garrison LP Jr. Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunities. Acad Radiol. 2014 Sep;21(9):1138-43.

Garrison LP. Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?—An Overview. Value in Health, July-August 2016

Garrison LP Jr, Carlson JJ, Bajaj PS, Towse A, Neumann PJ, Sullivan SD, Westrich K, Dubois RW. Private sector risk-sharing agreements in the United States: trends, barriers, and prospects. Am J Manag Care. 2015 Sep;21(9):632-40.

Garrison LP Jr, Lewin J, Young CH, Généreux P, Crittendon J, Mann MR, Brindis RG. The clinical and cost burden of coronary calcification in a Medicare cohort: An economic model to address under-reporting and misclassification. Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):406-12.. Epub 2015 Aug 12.

Garrison LP, Kamal-Bahl, S, Towse, A. Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost Effectiveness Analysis. Value in Health 20 (2017)

Towse A, Garrison L. Value Assessment in Precision Cancer Medicine, Journal of Cancer Policy 11 (2017) 48–53 3.

Garrison LP Jr, Zimmermann MR, Young CH, Crittendon J, Généreux P. Cost-effectiveness analysis of the orbital atherectomy system: Two-year follow-up. Cardiovasc Revasc Med. 2016 Dec 15.

Wirtz HS, Buist DSM, Gralow JR, Barlow WE, Gray SL, Chubak J, Yu O, Bowles EJA, Fujii M, Boudreau DM. Frequent antibiotic use and second breast cancer events. Cancer Epidemiol Biomarkers Prev 2013 In press

Lo-Ciganic WH, Boudreau R, Gray SL, Zgibor JC, Donohue JM, Perera S, Strotmeyer E, Bunker CH, Newman AB, Simonsick E, Bauer DC, Satterfield S, Hanlon JT for the Health ABC Study. 1 Time-Trend Utilization of Cholesterol-Lowering Medications in Community-Dwelling Older Adults: Impact of the 2002 National Cholesterol Education Program Guidelines and the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Ann of Pharmacother In press

Gray SL, Anderson M, Hubbard R, LaCroix A, Crane P, McCormick W, Bowen J, McCurry S, Larson EB. Frailty and Incident Dementia. Gerontol A: Biol Sci Med Sci 2013 First published online: February 18, 2013

Lo-Ciganic WH, Boudreau R, Gray SL, Zgibor JC, Donohue JM, Perera S, Strotmeyer E, Bunker CH, Newman AB, Simonsick E, Bauer DC, Satterfield S, Hanlon JT for the Health ABC Study. Time-Trend Utilization of CholesterolLowering Medications in Community-Dwelling Older Adults: Impact of the 2002 National Cholesterol Education Program Guidelines and the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Ann of Pharmacother 2013 In press

Gray SL, Anderson M, Hubbard R, LaCroix A, Crane P, McCormick W, Bowen J, McCurry S, Larson EB. Frailty and Incident Dementia. Gerontol A: Biol Sci Med Sci 2013 In press

Dublin S, Walker RL, Gray SL, Hubbard R, Anderson ML, Yu O, Crane PK, Larson EB. Prescription opioids and risk of dementia or cognitive decline J Am Geriatr Soc 2015 In press

Gray SL, Anderson ML, Dublin S, Hanlon JT, Walker RL, Hubbard R, Yu O, Crane PK, Larson EB. Cumulative use of strong anticholinergics and incident dementia JAMA Intern Med 2015 175(3):401-407. doi: 10.1001/ jamainternmed.2014.7663 [Epub ahead of print] NIHMS 665195

Lo-Ciganic WH, Perera S, Gray SL, Boudreau R, Zgibor JC, Strotmeyer E, Donohue JM, Bunker CH, Newman AB, Simonsick E, Bauer DC, Satterfield S, Caserotti P, Harris T, Shorr RI, Hanlon JT for the Health ABC Study. Statin Use and Gait-Speed Decline in Community-Dwelling Older Adults: Results from the Health, Aging and Body Composition Study J Am Geriatr Soc 2015;63:124-9. doi: 10.1111/jgs.13134. Epub 2014 Dec 23.

Gray SL, Dublin S, Yu O, Walker R, Anderson M, Crane P, Larson E Benzodiazepine use and risk of incident dementia or cognitive decline. BMJ. 2016;352:i90 PMC4737849

Golchin N, LaCroix A, Hohensee C, Gray SL. Nitrate medication use, fractures and change in bone mineral density in postmenopausal women: Results from the Women’s Health Initiative. J Bone Min Research. 2016 11 JUL 2016 DOI: 10.1002/jbmr.2838

Marcum Z, Wirtz HS, Pettinger M, LaCroix A, Carnahan R, Cauley JA, Bea J, Gray SL. Anticholinergic medication use and falls in postmenopausal women. BMC Geriatrics 2016;16:76.

Hansen RN, Nguyen HP, Sullivan SD. Bioequivalent Antiepileptic Drug Switching and the Risk of SeizureRelated Events. Epilepsy Research 2013. doi:pii: S0920- 1211(13)00127-7. 10.1016/j.eplepsyres.2013.04.010.

Batty A, Hansen RN, Bloudek LM, Varon SF, Hayward E, Lipton RB, Sullivan SD. Cost-effectiveness of OnabotulinumtoxinA for Prophylaxis of Headache in Adults with Chronic Migraine in the United Kingdom. Journal of Medical Economics 2013;16(7):877-87.

Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD. Estimating the Cost Effectiveness of BMontenovo

MI, Hansen RN, Dick AAS. Outcomes of Adult Liver Re-Transplant Patients in the MELD Era: Is it Time to Reconsider its Indications? Clinical Transplantation. In Press. July 2014.

Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to Oral Migraine Preventive Medications Among Patients with Chronic Migraine. Cephalagia. In Press. June 2014.

Luxton DD, Hansen RN, Stanfill KE. Mobile App Selfcare versus In-office Care for Stress Reduction: A Cost Minimization Evaluation. Journal of Telemedicine and Telecare. In Press. June 2014.OTOX for Neurogenic Detrusor Overactivity in the US. Clinical Therapeutics 2013;35(4):414-24.

Hansen RN, Boudreau DM, Ebel BE, Grossman DC, Sullivan SD. Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash. American Journal of Public Health. In Press, April 15, 2015.

Chou R, Deyo R, Devine B, Hansen RN, Sullivan S, Jarvik JG, Blazina I, Dana T, Bougatsos C, Turner J. The Effectiveness and Risks of Long-term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. Annals of Internal Medicine. 2015;162(4):276-86

Hansen RN, Hackshaw MD, Nagar SP, Arondekar B, Deen KC, Sullivan SD, Ramsey SD. Healthcare Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib. Journal of Managed Care and Specialty Pharmacy. 2015;21(1):37-44

Farias AJ, Hansen RN, Zeliadt SB, Ornelas I, Li C, Thompson B. The association between out-of-pocket costs and adherence to adjuvant endocrine therapy among newly diagnosed breast cancer patients. American Journal of Clinical Oncology 2016. In Press.

Dilokthornsakul P, Hansen RN, Campbell JD. Forecasting US Ivacaftor Outcomes and Cost in Cystic Fibrosis Patients with G551D Mutation. European Respiratory Journal 2016;47(6):1697- 1705. Hoogendoorn M,

Feenstra TL, Asukai Y, Briggs AH, Borg S, Dal Negro RW, Hansen RN, Jansson S, Leidl R, Risebrough N, Samyshkin Y, Wacker ME, Rutten-van Molken MPMH. Patient heterogeneity in health economic decision models for chronic obstructive pulmonary disease (COPD): are current models suitable to evaluate personalized medicine? Value In Health 2016. In Press.

Von Korff MR, Walker RL, Saunders K, Shortreed SM, Thakral M, Parchman M, Hansen RN, Ludman E, Sherman K, Dublin S. Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. International Journal of Drug Policy 2017. In Press.

Hansen RN, Pham AT, Lovelace B, Balaban S, Wan GJ. Comparative Analysis of Inpatient Costs for Obstetrics and Gynecology Surgery Patients Treated with IV Acetaminophen and IV Opioids versus IV Opioid Monotherapy for Postoperative Pain. Annals of Pharmacotherapy 2017. In Press.

Dick AAS, Hansen RN, Montenovo MI, Healey PJ, Smith JM. Body Mass Index as a Predictor of Outcomes Among Pediatric Kidney Transplant Recipient. Pediatric Transplantation 2017. In Press.

Graves JM, Fulton-Kehoe D, Jarvik JG, Franklin GM. Health care utilization and costs associated with adherence to clinical practice guidelines for early magnetic resonance imaging among workers with acute occupational low back pain. Health Services Research, 2013, In Press.

Graves JM, Vavilala MS, Kanal KM, Jarvik JG, Rivara F. Dose reduction efforts for pediatric head CT imaging in Washington State trauma centers: follow-up survey results. Journal of the American College of Radiology, 2013, In Press.

Lee CI, Bensink ME, Berry K, Musa Z, Bodnar C, Dann R, Jarvik JG, Lehman CD, Ramsey SD. Performance goals for an adjunct test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences. Journal of the American College of Radiology, 2013, In Press.

Friedly J, Bauer Z, Comstock B, DiMango E, Ferrara A, Huang SS, Israel E, Jarvik JG, Nierenberg AA, Ong MK, Penson D, Smith-Bindman R, Stillman AE, Vollmer WM, Warren S, Zha C, Hsia D CW, Trontell A. Challenges Conducting Comparative Effectiveness Research: The Clinical And Health Outcomes Initiative in Comparative Effectiveness (CHOICE). Experience. Journal of Comparative Effectiveness Research. 2014, In Press.

Deyo RA, Jarvik JG, Chou R. Low Back Pain in Primary Care. British Medical Journal 349:g4266 2014.

Andreisek G, Winklhofer SF-X, Deyo R, Jarvik JG, Porchet F. Consensus conference on core radiologic parameters to describe lumbar stenosis – an initiative for structured reporting. European Radiology, 2014, In Press.

Jarvik JG, Gold LS, Comstock BA, Heagerty PJ, Rundell SD, Turner JA, Avins AL, Bauer Z, Bresnahan BW, Friedly JL, James K, Kessler L, Nedeljkovic SS, Nerenz DR, Shi X, Sullivan SD, Chan L, Schwalb JM, Deyo RA. Association of early imaging for back pain with clinical outcomes in older adults. JAMA, Mar 17;313(11):1143-53, 2105. PMID:25781443

Deyo RA1 , Bryan M, Comstock BA, Turner JA, Heagerty P, Friedly J, Avins AL, Nedeljkovic SS, Nerenz DR, Jarvik JG. Trajectories of Symptoms and Function in Older Adults with Low Back Disorders Spine (Phila Pa 1976). 2015 May 20. [Epub ahead of print]

Turner JA1 , Comstock BA2, Standaert C3, Heagerty PJ2, Jarvik JG4, Deyo RA5, Wasan AD6, Nedeljkovic SS7 , Friedly JL3. Can Patient Characteristics Predict Benefit from Epidural Corticosteroid Injections for Lumbar Spinal Stenosis Symptoms? Spine J. 2015 Jun 18. [Epub ahead of print]

Jarvik JG, Comstock BA, Bresnahan BW, Nedeljkovic SS, Nerenz DR, Bauer Z, Avins AL, James K, Turner JA, Heagerty P, Kessler LG, Friedly JL, Sullivan SD, Deyo RA. (2012) Study Protocol: The Back pain Outcomes using Longitudinal Data (BOLD) Registry. BMC Medicine 2012 May 3, 13:64.

Klein G, Gold LS, Sullivan SD, Buist DS, Ramsey S, Kreizenbeck K, Snell K, Loggers ET, Gifford J, Watkins JB, Kessler L. (2012) Prioritizing comparative effectiveness research for cancer diagnostics using a regional stakeholder approach. Journal of Comparative Effectiveness Research May 2012; 1 (3): 241-255.

Kessler, Larry. (2013) Is 20% of a Loaf Enough? Cancer. 2013 Apr 1; 119 (7): 1294-7. doi: 10.1002/cncr.27811. Epub 2013 Feb 25.

Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, Bauer Z, Bresnahan BW, Avins AL, Nedeljkovic SS, Nerenz DR, Standaert C, Kessler L, Akuthota V, Annaswamy T, Chen A, Diehn F, Firtch W, Gerges FJ, Gilligan C, Goldberg H, Kennedy DJ, Mandel S, Tyburski M, Sanders W, Sibell D, Smuck M, Wasan A, Won L, Jarvik JG. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014 Jul 3;371(1):11-21. doi: 10.1056/ NEJMoa 1313265. PMID: 24988555

Flum DR, Alfonso-Cristancho R, Devine EB, Devlin A, Farrokhi E, Tarczy-Hornoch P, Kessler L, Lavallee D, Patrick DL, Gore JL, Sullivan SD; CERTAIN Collaborative. Implementation of a “real-world” learning health care system: Washington state’s Comparative Effectiveness Research Translation Network (CERTAIN). Surgery. 2014 May;155 (5):860-6. doi: 10.1016/j.surg.2014.01.004. PMID: 24787113

Jarvik JG, Comstock BA, Heagerty PJ, Turner JA, Sullivan SD, Shi X, Nerenz DR, Nedeljkovic SS, Kessler L, James K, Friedly JL, Bresnahan BW, Bauer Z, Avins AL, Deyo RA. Back pain in seniors: the Back pain Outcomes using Longitudinal Data (BOLD) cohort baseline data. BMC Musculoskelet Disord. 2014 Apr 23;15(1):134. doi: 10.1186/1471- 2474-15-134. PMID: 24755158 PMCID: PMC4021204

Friedly JL, Comstock BA, Turner JA, Heagerty PJ, Deyo RA, Sullivan SD, Bauer Z, Bresnahan BW, Avins AL, Nedeljkovic SS, Nerenz DR, Standaert C, Kessler L, Akuthota V, Annaswamy T, Chen A, Diehn F, Firtch W, Gerges FJ, Gilligan C, Goldberg H, Kennedy DJ, Mandel S, Tyburski M, Sanders W, Sibell D, Smuck M, Wasan A, Won L, Jarvik JG. A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med. 2014 Jul 3;371(1):11-21. doi: 10.1056/ NEJMoa 1313265. PMID: 24988555

Flum DR, Alfonso-Cristancho R, Devine EB, Devlin A, Farrokhi E, Tarczy-Hornoch P, Kessler L, Lavallee D, Patrick DL, Gore JL, Sullivan SD; CERTAIN Collaborative. Implementation of a “realworld” learning health care system: Washington state’s Comparative Effectiveness Research Translation Network (CERTAIN). Surgery. 2014

MJarvik JG, Comstock BA, Heagerty PJ, Turner JA, Sullivan SD, Shi X, Nerenz DR, Nedeljkovic SS, Kessler L, James K, Friedly JL, Bresnahan BW, Bauer Z, Avins AL, Deyo RA. Back pain in seniors: the Back pain Outcomes using Longitudinal Data (BOLD) cohort baseline data. BMC Musculoskelet Disord. 2014 Apr 23;15 (1):134. doi: 10.1186/1471-2474-15-134. PMID: 24755158 PMCID: PMC4021204ay;155(5):860-6. doi: 10.1016/ j.surg.2014.01.004. PMID: 24787113

Lyman GH, Benson AB, Bosserman L, Burstein HJ, Cody HS, Edge SB, Hayman JA, Newman LA, Perkins CL, Podoloff DA, Turner RR, Weaver DL, Giuliano AE: Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, J Clin Oncol 2014; 32: 1365-1383.

Lyman GH, Abella S, Pettengell R: Risk Factors for Febrile Neutropenia Among Patients with Cancer Receiving Chemotherapy: A Systematic Review. Crit Rev Oncol Hematol 2014; 90: 190-199.

Lyman GH: Impact of Venous Thromboembolism on Survival in Patients with Advanced Cancer: An Unmet Clinical Need. Intern Emerg Med 2014 (in press).

Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009. JAMA Oncol. 2015 May 1;1(2):158-66.

Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Schilsky RL. American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. J Clin Oncol. 2015 Jun 22. [Epub ahead of print]

Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A; American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update 2014. J Clin Oncol. 2015 Feb 20;33(6):654-6. Epub 2015 Jan 20.

Ramsey SD, Sullivan SD, Reed, SD, Shih YT, Schaecher K, Dhanda R, Patt D, Pendergrass K, Walker M, Malin J, Schwartzberg L, Neumann K, Yu E, Ravelo A, Small A. Oncology Comparative Effectiveness Research: A MultiStakeholder Perspective on Principles for Conduct and Reporting. Oncologist. In Press

Carlson JJ, Thariani R, Roth J, Gralow J, Henry NL, Esmail L, Deverka P, Ramsey SD, Baker L, Veenstra DL. Value of Information Analysis within a StakeholderDriven Research Prioritization Process: An application in Cancer Genomics. Medical Decision Making. In Press

Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KAB, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN. Comparative Effectiveness Research in Cancer Genomics and Precision Medicine: Current Landscape and Future Prospects. Journal of the National Cancer Institute. 2013. Commentary: 1 – 8.

Barocas DA, Bensink ME, Berry K, Musa Z, Bodnar C, Dann R, Ramsey SD. Economic evaluation of diagnostic localization following biochemical prostate cancer recurrence. In press, International J Tech Assess Healthcare.

Seal, B, Sullivan SD, Ramsey SD, Asche CV, Shermock K, Sarma S, Zagadailov EA, Farrelly E, Eaddy M. 2014. Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases. Applied health economics and health policy. Jul 9; Epub ahead of print.

Unger, JM, Barlow WE, Martin DP, Ramsey SD, LeBlanc M, Etzioni R, Hershman DL. 2014. Comparison of Survival Outcomes Among Cancer Patients Treated In and Out of Clinical Trials. Journal of the National Cancer Institute. 106 (3): 1-13.

Ramsey SD, Fedorenko C, Chauhan R, McGee R, Lyman GH, Kreizenbeck K, Bansal A. Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer. J Oncol Pract. 2015. Epub 2015/06/11. doi: 10.1200/jop.2014.002717. PubMed PMID: 26060225.

Ramsey SD, Henry NL, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL. Tumor marker usage and medical care costs among older early-stage breast cancer survivors. J Clin Oncol. 2015;33(2):149-55. Epub 2014/10/22. doi: 10.1200/ jco.2014.55.5409. PubMed PMID: 25332254; PMCID: Pmc4279234.

Ramsey SD, Willke RJ, Glick H, Reed SD, Augustovski F, Jonsson B, Briggs A, Sullivan SD. Cost-Effectiveness Analysis Alongside Clinical Trials II-An ISPOR Good Research Practices Task Force Report. Value Health. 2015;18(2):161-72. Epub 2015/0

Unger, JM, Barlow WE, Ramsey SD, LeBlanc M, Blanke CD, Hershman DL. The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials. JAMA Oncol. 2016 Mar 10. doi: 10.1001/jamaoncol.2015.6487. [Epub ahead of print]. PMID: 26967260.

Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet K, Shankaran V, Newcomb P. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016 Mar 20;34(9):980-6. doi: 10.1200/JCO.2015.64.6620. Epub 2016 Jan 25. PMID: 26811521.

Bennette CS, Veenstra DL, Basu A, Baker LH, Ramsey SD, et al. Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group. Med Decis Making. 2016 Mar 24. pii: 0272989X16636847. [Epub ahead of print]. PMID: 27012232

Bennette CS, Veenstra DL, Basu A, Baker LH, Ramsey SD, Carlson JJ. Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group. Med Decis Making. 2016 Jul;36(5):641-51. doi: 10.1177/0272989X16636847. Epub 2016 Mar 24. PMID: 27012232

Mandelblatt JS, Ramsey SD, Lieu TA, Phelps CE. Evaluating Frameworks That Provide Value Measures for Health Care Interventions. Value Health. 2017 Feb;20(2):185-192. doi: 10.1016/ j.jval.2016.11.013. PMID: 28237193

Bansal A, Sullivan SD, Hershman DL, Lyman GH, Barlow WE, McCune JS, Ramsey SD. A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study. J Comp Eff Res. 2017 Jul 7. [Epub ahead of print]

Roth, JA, Sullivan SD, Goulart BHL, Ravelo A, Sanderson JC, Ramsey SD. 2015. Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.. Journal of oncology practice / American Society of Clinical Oncology. 11(4):267-72.

Roth, JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D. 2015. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.. Pharmacoepidemiology and drug safety

Wang, B, Roth JA, Nguyen H, Felber E, Furnback W, Garrison LP. 2015. The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States.. PloS one. 10(4):e0121915.

Roth JA, Ramsey SD, Carlson JJ. Cost-Effectiveness of a BiopsyBased 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer. Oncologist. 2015 Dec;20(12):1355-64. doi: 10.1634/theoncologist.2015-0214. Epub 2015 Oct 19. PubMed PMID: 26482553; PubMed Central PMCID: PMC4679086.

Roth JA, Ramsey SD. Computed Tomography Screening for Lung Cancer: A High-Value Proposition? JAMA. 2016 Jan 5;315(1):77- 8. doi: 10.1001/jama.2015.17877. PubMed PMID: 26746460

Roth JA, Gulati R, Gore JL, Cooperberg MR, Etzioni R. Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies. JAMA Oncol. 2016 Mar 24. doi: 10.1001/ jamaoncol.2015.6275. [Epub ahead of print] PubMed PMID: 27010943

Hart R, Veenstra DL, Boudreau DM, Roth JA. The Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting. Am J Med. 2016 Sep 1. pii: S0002-9343(16) 30860-9. PubMed PMID: 27593608.

Carter-Harris L, Brandzel S, Wernli KJ, Roth JA, Buist DS. A qualitative study exploring why individuals opt out of lung cancer screening. Fam Pract. 2017 Jan 24. pii: cmw146. [Epub ahead of print] PubMed PMID: 28122849.

Roth JA, Goulart BHL, Ravelo A, Kolkey H, Ramsey SD. Survival Gains from First‐Line Systemic Therapy in Metastatic Non‐ Small Cell Lung Cancer in the U.S., 1990–2015: Progress and Opportunities. The Oncologist. 2017 Feb 27. PMID: 28242792.

Hussien N, Musa S, Stergachis A, Wabe NT, Suleman S. Drug Information : Prescribers’ Need for and Access to Drug Information Resources in Ethiopia. Therapeutic Innovation & Regulatory Science. 2013;47(2):219-225.

Stergachis A, Keene D, Somani S. Informatics for Medicines Management Systems in Resource-Limited Settings. In: Gasmelseid TM (ed). Handbook of Research on Pharmacoinformatics. IGI publishing, USA. 2012.

Dellicour S, Brasseur P, Thorn P, Gaye O, Olliaro P, Badiane M, Stergachis A, Kuile FO. Probabilistic record linkage for monitoring the safety of artemisinin based combination therapy in the first trimester of pregnancy in Senegal. Drug Safety. 2013 Jul;36(7):505-13.

Sangare L, van Eijk AM, ter Kuile FO, Walson J, Stergachis A. The association between malaria and iron status or supplementation in pregnancy: a systematic review and metaanalysis. PLoS ONE. 2014;Feb 14;9:e87743.

Kovacs S, Hawes SE, Maley SN, Mosites E, Wong L, Stergachis A. Technologies for detecting falsified and substandard drugs in low and middle income countries. PLoS ONE. 2014. 9: e90601.

Roth GA, Gillespie CW, Mokdad AA, Shen DD, Fleming DW, Stergachis A, Murray CJL, Mokdad AH. Aspirin use and knowledge in the community: a population and health facility based survey for measuring local health system performance. BMC Cardiovascular Disorders. 2014. 14:16.

Nwokike J, Kabore L, Stergachis A. Actions of the national regulatory authorities in 10 low- and middle-income countries following stringent regulatory authority safety alerts on rosiglitazone. Therapeutic Innovation & Regulatory Science. 2015;49:279-283.

Kovacs SD, Rijken M, Stergachis A. Treating severe malaria in pregnancy: a review of the evidence. Drug Safety. 2015;38:165-81.

Wagenaar BH, Stergachis A, Hoek R, Cumbe V, Rao D, Napúa M, Sherr K. The availability of essential medicines for mental healthcare in Sofala, Mozambique. Global Health Action. 2015 Jun 15;8:27942.

Tinto H, Sevene E, Dellicour S, Calip GS, d’Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, Valá A, Augusto O, Ruperez M, Menendez C, Ouma P, Desai M, ter Kuile F, Stergachis A. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Reproductive Health. 2015 Dec, 12:112.

Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison LP, Stergachis A. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost Utility Analysis. Drug Saf. 2016 Jun 17. [Epub ahead of print].

Moradi-Lakeh M, El Bcheraoui C, Daoud F, Tuffaha M, Wilson S, Al Saeedi M, Basulaiman M, Memish ZA, AlMazroa MA, Al Rabeeah AA, Stergachis A, Mokdad AH. Medication use for chronic health conditions among adults in Saudi Arabia: findings from a national household survey. Pharmacoepidemiol Drug Saf. 2016;25):73-81.

Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Mayando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Ruperez M, Macete E, Menendez C, Nakanabo-Diallo S, Kazienga A, Valea I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d’Alessandro U, Nosten F, ter Kuile F; Stergachis A.

First trimester artemisinin derivatives and quinine treatments and their association with adverse pregnancy outcomes in Africa and Asia: a metaanalysis of observational studies. PLOS Medicine. 2017 May 2;14 (5):e1002290. Jenny AM, Li M, Ashbourne E, Aldrink M, Funk C, Stergachis A. Assessment of the scope and evaluation of medical donation programs. Globalization and Health. 2016 Nov 4;12(1):69.

Mugwanya KK, Celum CL, John-Stewart GC, Mugo N, Katabira E, Bulya N, Ngure N, Stergachis A, Baeten J. Infant exposure to tenofovir and emtricitabine through breast milk when used as preexposure prophylaxis by HIV-uninfected lactating women. PLoS Med. 2016 Sep 27;13(9):e1002132.

Miquel-Cases A, Steuten LM, Retèl VP, van Harten WH. Early stage cost-effectiveness analysis of a BRCA1-like test to detect triple negative breast cancers responsive to high dose alkylating chemotherapy. Breast. 2015 Aug;24(4):397-405. doi: 10.1016/j. breast.2015.03.002. Epub 2015 Apr 28. PubMed PMID: 25937263.

Deeg HJ, Steuten LM. Therapy for Hematologic Cancers in Older Patients, Quality of Life, and Health Economics: Difficult Decisions. JAMA Oncol. 2015 Jun 11. doi: 10.1001/jamaoncol.2015.1084. [Epub ahead of print] PubMed PMID: 26181003.

Mewes JC, Steuten LM, Duijts SF, Oldenburg HS, van Beurden M, Stuiver MM, Hunter MS, Kieffer JM, van Harten WH, Aaronson NK. Cost effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv. 2015 Mar;9(1):126-35. doi: 10.1007/s11764- 014-0396-9. Epub 2014 Sep 2. PubMed PMID: 25179578

Miquel-Cases A, Retèl VP, van Harten WH, Steuten LM. Decisions on Further Research for Predictive Biomarkers of High-Dose Alkylating Chemotherapy in Triple-Negative Breast Cancer: A Value of Information Analysis. Value Health. 2016 Jun;19(4):419-30. doi: 10.1016/j.jval.2016.01.015. Epub 2016 Apr 6. PubMed PMID: 27325334.

Steuten LM. Multi-Dimensional Impact of the Public-Private Center for Translational Molecular Medicine (CTMM) in the Netherlands: Understanding New 21(st) Century Institutional Designs to Support Innovation-in-Society. OMICS. 2016 May;20(5):265-73. doi: 10.1089/omi.2016.0042. PubMed PMID: 27195965; PubMed Central PMCID: PMC4876525.

Oosterhoff M, van der Maas ME, Steuten LM. A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers. Appl Health Econ Health Policy. 2016 Feb;14(1):51-65. doi: 10.1007/s40258-015-0198-x. PubMed PMID: 26334528; PubMed Central PMCID: PMC4740568.

Sullivan SD, Dalal MR, Burke J. The Impact of Diabetes Counseling and Education: Clinical and Cost Outcomes From a Large Population of US Managed Care Patients with Type 2 Diabetes. The Diabetes Educator, In press

Sullivan SD, Hansen RN, Carlson, JD. Comparative effectiveness research in the US: A progress report. Journal of Medical Economics 2013;16(2):295-7.

Sullivan SD, Alfonso-Cristancho R, Mallya U, Ringold S. Economic consequences of sequencing biologics in rheumatoid arthritis: A systematic review. Journal of Medical Economics 2013;16(3):391-6.

Ramsey SD, Sullivan SD. A new model for reimbursing genome-based cancer care. The Oncologist 2014 19:1-4.

Pauly M, Frank R, Sullivan SD. An economic framework for preventive care advice. In press Health Affairs 2014

Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget Impact Analysis Principles of Good Practice: Report of the ISPOR Budget Impact Analysis Good Practice II Task Force. Value in Health 2014 17:5-14

Sullivan SD, Yeung K, Vogeler C, et al. Design, implementation, and first-year outcomes of a value-based drug formulary. Journal of Managed Care and Specialty Pharmacy 2015 Apr;21(4):269-75

Pauly MV, Sloan FA, Sullivan SD. An economic framework for preventive care advice. Health Affairs 2014 33(11):2034-2040.

Roth JA, Sullivan SD, Goulart B, Ravelo A, Sanderson JC, Ramsey SD. Projected clinical, resource use and fiscal impact of implementing low-dose computed tomography lung cancer screening in Medicare. Journal of Oncology Practice 2015 Jul;11(4):267-72.

McDougall JA, Bansal A, Goulart BH, McCune J, Karnopp A, Fedorenko C, Geenlee S, Valderama A, Sullivan SD, Ramsey SD. The Clinical and Economic Impacts of Skeletal Related Events Among Medicare Enrollees with Prostate Cancer Metastatic to Bone. The Oncologist 2016 Mar;21(3):320-6.

Bennette CS, Richards C, Sullivan SD, Ramsey SD. Trends and determinants of oral anticancer drug costs after market introduction. Health Affairs in press, 2016

Loggers ET, Buist DSM, Gold LS, Zeliadt S, Hunter-Merrill S, Etzioni R, Ramsey SD, Sullivan SD, Kessler LG. Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer. Int J of Breast Cancer in press.

Mathai SC, Minai O, Sullivan SD, Lerner D, Levine D. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment. Respir Med 2017 Jan;122 Suppl 1:S23-S27

Bansal A, Sullivan SD, Lyman G, Hershman D, Barlow WE, McCune J, Ramsey SD. A Stakeholder-Informed Randomized, Controlled Comparative Effectiveness Study of an Order Prescribing Intervention to Improve Colony Stimulating Factor use for Cancer Patients Receiving Myelosuppressive Chemotherapy, (SWOG S1415CD): The TrACER Study. Journal of Comparative Effectiveness Research 2017 (Jul) e-pub ahead of press.

Canestaro WJ, Hendrix N, Bansal A, Sullivan SD, Devine EB, Carlson JJ. Predictors of Publication for Biomedical Research: A Systematic Review and Meta-Analysis. J Clin Epi in press, 2017

Feero WG, Wicklund C, Veenstra DL. The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health. JAMA. 2013 Mar 27;309(12):1235-6. doi: 10.1001/ jama.2013.113. PMID: 23532238

Bennette CS, Trinidad SB, Patrick D, Amendola L, Burke W, Hisama FM, Jarvik GP, Regier DA, Veenstra DL. Return of Incidental Findings in Genomic Medicine: Measuring What Patients Value. Development of an Instrument to Measure PReferences for Information from Next-generation Testing (IMPRINT). Genetics in Medicine 2013, In press.

Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. The Validity of Dependence as a Health Outcome Measure in Alzheimer’s Disease. Am J Alzheimers Dis Other Demen. 2013 Mar 19. [Epub ahead of print]

Thariani R, Henry NL, Ramsey SD, Blough DK, Barlow B, Gralow JR, Veenstra DL. Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis. J Comp Eff Res. 2013 May;2(3):325-34. doi: 10.2217/cer.13.15. PMID: 24236631

Feero WG, Wicklund C, Veenstra DL. The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health. JAMA. 2013 Mar 27;309(12):1235-6. doi: 10.1001/jama.2013.113. PMID: 23532238

Bennette CS, Trinidad SB, Patrick D, Amendola L, Burke W, Hisama FM, Jarvik GP, Regier DA, Veenstra DL. Return of Incidental Findings in Genomic Medicine: Measuring What Patients Value. Development of an Instrument to Measure PReferences for Information from Next-generation Testing (IMPRINT). GenetMed. 2013 Nov;15(11):873-81. PMID: 23722871

Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, Horike-Pyne M, Hisama FM, Pritchard CC, Grady WM, Burke W, Jarvik GP, Veenstra DL. Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost Effectiveness Analysis. J Clin Oncol. 2015 Jun 20;33(18):2084-91. doi: 10.1200/JCO.2014.59.3665. Epub 2015 May 4. PMID: 25940718

Bennette CS, Gallego CJ, Burke W, Jarvik GP, Veenstra DL. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing. Genet Med. 2015 Jul 2;17(7):587-95. doi: 10.1038/ gim.2014.156. Epub 2014 Nov 13. PMID: 25394171 Free PMC Article

Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P, Grady WM, Fullerton SM, Trinidad SB, Regier DA, Nickerson DA, Burke W, Patrick DL, Jarvik GP, Veenstra DL.Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/ polyposis syndromes. Contemp Clin Trials. 2014 Sep;39(1):1-8. doi: 10.1016/j.cct.2014.06.016. Epub 2014 Jul 3. PMID: 24997220 Free PMC Article

Veenstra DL., The value of routine pharmacogenomic screening – Are we there yet? A perspective on the costs and benefits of routine screening – shouldn’t everyone have this done? Clin Pharmacol Ther. 2016 Feb;99(2):164-6. doi: 10.1002/cpt.299. Epub 2015 Dec 23.PMID: 26565561

Basu A, Carlson JJ, Veenstra DL.A Framework for Prioritizing Research Investments in Precision Medicine. Value Health. 2015 Nov;18(7):A729. doi: 10.1016/j.jval.2015.09.2777. Epub 2015 Oct 20. No abstract available. PMID: 26534083 Similar articles Select item 26533910

Canestaro WJ, Pritchard DE, Garrison LP, Dubois R, Veenstra DL. Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT). J Manag Care Spec Pharm. 2015 Aug;21 (8):700-12. Review. PMID: 26233542

Dhanda DS, Guzauskas GF, Carlson JJ, Basu A, Veenstra DL. Are evidence standards different for genomic- vs. clinical-based precision medicine? – A quantitative analysis of individualized warfarin therapy. Clin Pharmacol Ther. 2017 Feb 10. PMID: 28187492

Guzauskas GF, Chen E, Lalla D, Yu E, Tayama D, Veenstra DL. What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients? Int J Stroke. 2017 Feb;12 (2):137-144. PMID: 28134053 Serbin MA,

Guzauskas GF, Veenstra DL. Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis. J Manag Care Spec Pharm. 2016 Aug;22(8):939-47. PMID: 27459657

Wright DR, Lozano P, Dawson-Hahn EE, Christakis DA, Haaland WL, Basu A. Parental Predictions and Perceptions Regarding Long -Term Childhood Obesity-Related Health Risks. Academic Pediatrics. July 2016; 16: 475-481.

Wright DR, Haaland WL, Ludman E, McCauley E, Lindenbaum J, Richardson LP. The costs and cost-effectiveness of collaborative care for adolescents with depression in primary care settings. JAMA Pediatrics [In Press]

Lion KC, Wright DR, Spencer, Zhou C, Del Beccaro M, MangioneSmith R. “Standardized Clinical Pathway Care and Improved Outcomes among Hospitalized Children.” Pediatrics. April 2016; 137 (4): doi: 10.1542/peds.2015-1202. PMID: 27002007

Wright DR, Lozano P, Dawson-Hahn EE, Christakis DA, Haaland WL, Basu A. “Parental optimism about childhood obesity-related disease risks.” International Journal of Obesity. May 2017. doi:10.1038/ijo.2017.103

Wright DR, Lozano P, Dawson-Hahn EE, Christakis DA, Haaland WL, Basu A. “Parental Predictions and Perceptions Regarding Long-Term Childhood Obesity-Related Health Risks.” Academic Pediatrics. July 2016; 16: 475-481. PMID: 26875508.

Wright DR, Haaland WL, Ludman E, McCauley E, Lindenbaum J, Richardson LP. “The costs and cost-effectiveness of collaborative care for adolescents with depression in primary care settings.” JAMA Pediatrics. November 2016; 170(11): 1048-1054. PMID: 26875508.